RHONDA HEWITT: Open Payments
NPI 1649289943 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208,934 in 481 payments from 21 companies in 2025. Trend: 2023 $207,978 · 2024 $175,761 · 2025 $208,934
Speaker / faculty: $147,883Travel & lodging: $42,326Food & beverage: $11,285Speaker / faculty: $7,440
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 270 | $125,616 |
| BeOne Medicines USA, Inc. | 46 | $25,632 |
| Incyte Corporation | 44 | $13,957 |
| AstraZeneca Pharmaceuticals LP | 27 | $12,399 |
| SERVIER PHARMACEUTICALS LLC | 30 | $11,937 |
| Syndax Pharmaceuticals, Inc. | 22 | $9,734 |
| BeiGene USA, Inc. | 11 | $7,665 |
| GlaxoSmithKline, LLC. | 2 | $729 |
| Amgen Inc. | 1 | $250 |
| Rigel Pharmaceuticals, Inc. | 3 | $170 |
Products named: RYBREVANT, BRUKINSA, Jakafi, Tibsovo, REVUFORJ, CALQUENCE, OJJAARA, BLINCYTO.
Industry payments across CA — which companies pay providers there.
